In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer (Q27853236)
Jump to navigation
Jump to search
scientific article
- In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer |
scientific article |
|
Statements
2 references
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer (English)
2 references
Toshiyuki Hirano
Hiroyuki Yasuda
Tetsuo Tani
Junko Hamamoto
Ayano Oashi
Kota Ishioka
Daisuke Arai
Shigenari Nukaga
Masayoshi Miyawaki
Ichiro Kawada
Katsuhiko Naoki
Susumu S Kobayashi
Tomoko Betsuyaku
Kenzo Soejima
1 November 2015
1 reference
Identifiers
2 references
2 references
2 references